Steritas announces collaboration with argenx to advance evidence for novel steroid-sparing therapeutics
Steritas LLC., a company dedicated to enhancing care for steroid-treated patients, today announced a licensing agreement with argenx, a global immunology company, for use of its STOX® Suite of steroid-toxicity…